ThromboEmbolism Prevention Efficacy and Safety Trial (TEMPEST)
Clinical trial NCT00041509 · COMPLETED
Trial details
- NCT number
- NCT00041509
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-01-01
- Primary completion
- 2003-05-01
- Enrollment
- 343
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.